Cartesian Therapeutics (RNAC) Capital Expenditures (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Capital Expenditures of $59000.0 for Q1 2026, down 88.97% year-over-year from $535000.0 in Q1 2025, and down 88.01% quarter-over-quarter from $492000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Capital Expenditures (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 11 years of Capital Expenditures data on file, last reported at $59000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $59000.0, down 88.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (down 48.3% YoY), and the FY2025 annual result was $5.5 million, down 40.02% from the prior year.
- Capital Expenditures fell to $59000.0 in Q1 2026 per RNAC's latest filing, from $492000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $6.2 million in Q3 2024 and troughed at -$77000.0 in Q3 2023.
- A 5-year average of $995937.5 and a median of $323500.0 in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures plunged 117.66% in 2023, then soared 18141.67% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $211000.0 in 2022, then plunged by 70.14% to $63000.0 in 2023, then soared by 1019.05% to $705000.0 in 2024, then tumbled by 30.21% to $492000.0 in 2025, then plunged by 88.01% to $59000.0 in 2026.
- Business Quant data shows RNAC's Capital Expenditures at $59000.0 in Q1 2026, $492000.0 in Q4 2025, and $4.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | 59,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,000.00 |
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | 492,000.00 |
| Dec 31, 2025 | 492,000.00 |
| Sep 30, 2025 | 4.27 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 153,000.00 |
| Jun 30, 2025 | 153,000.00 |
| Mar 31, 2025 | 535,000.00 |
| Mar 31, 2025 | 535,000.00 |
| Dec 31, 2024 | 705,000.00 |
| Dec 31, 2024 | 705,000.00 |
| Sep 30, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Dec 31, 2023 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | -77,000.00 |
| Sep 30, 2023 | -77,000.00 |